Skip to main content
Log in

Endotoxin tolerance diminishes certain antiinflammatory effects of endotoxin

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Endotoxin (bacterial lipopolysaccharide, LPS) is paradoxically both inflammatory and antiinflammatory. A single intravenous injection of 100μgEscherichia coli LPS markedly inhibits the inflammatory changes associated with cutaneous reversed passive Arthus (RPA) reactions in New Zealand white rabbits. Polymorphonuclear (PMN) leukocytes from LPS-treated rabbits exhibit diminished responsiveness in vitro to complement (C5) -derived peptides. Repeated injections of LPS render animals “tolerant”, that is, refractory to the toxic and inflammatory efects of LPS. We examined whether tolerance would enhance the ability of LPS to inhibit inflammation not attributable to LPS. Surprisingly, as compared with rabbits receiving a single dose of LPS, tolerant rabbits demonstrated greater inflammatory changes (i.e., PMN exudation, vascular permeability) associated with RPA reactions. PMNs from LPS-tolerant rabbits responded in vitro to C5-derived peptides significantly more than PMNs from rabbits that received a single dose of LPS. We speculate that some antiinflammatory effects of LPS require the toxic or inflammatory effects of LPS itself. These observations might relate to the limited efficacy of fever therapy and the variable effects of gram-negative sepsis on functions of human PMNs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gilbert, V. E., andA. I. Braude. 1962. Reduction of serum complement in rabbits after injection of endotoxin.J. Exp. Med. 116:477–490.

    Google Scholar 

  2. `Morrison, D. C., andL. F. Kline. 1977. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).J. Immunol. 118:362–368.

    Google Scholar 

  3. Kimball, H. R., K. L. Melmon, andS. M. Wolff. 1972. Endotoxin-induced kinin production in man.Proc. Soc. Exp. Biol. Med. 139:1078–1082.

    Google Scholar 

  4. Shen, S. M.-C., S. I. Rapaport, andD. I. Feinstein. 1973. Intravascular clotting after endotoxin in rabbits with impaired intrinsic clotting produced by a factor VIII antibody.Blood 42:523–534.

    Google Scholar 

  5. Wolff, S. M., J. H. Mulholland, andS. B. Ward. 1965. Quantitative aspects of the pyrogenic response of rabbits to endotoxin.J. Lab. Clin. Med. 65:268–276.

    Google Scholar 

  6. Cousins, S. W., J. T. Rosenbaum, R. B. Guss, andP. R. Egbert. 1982. Ocular albumin fluorophotometric quantitation of endotoxin-induced vascular permeability.Infect. Immun. 36:730–736.

    Google Scholar 

  7. Morrison, D. C., andJ. L. Ryan. 1979. Bacterial endotoxins and host immune responses.Adv. Immunol. 28:293–450.

    Google Scholar 

  8. Kurland, J. I., andR. S. Bockman. 1978. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.J. Exp. Med. 147:952–957.

    Google Scholar 

  9. Stuart, M. J. 1981. Effect of endotoxin on arachidonic acid release and thromboxane B2 production by human platelets.Am. J. Hematol. 11:159–164.

    Google Scholar 

  10. Dahinden, C., C. Galanos, andJ. Fehr. 1983. Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity.J. Immunol. 130:857–862.

    Google Scholar 

  11. Humphrey, J. H. 1955. The mechanism of Arthus reactions. I. The role of polymorphonuclear leukocytes and other factors in reversed passive Arthus reactions in rabbits.Br. J. Exp. Pathol. 36:268–282.

    Google Scholar 

  12. Rosenbaum, J. T., K. T. Hartiala, R. O. Webster, E. L. Howes, Jr., andI. M. Goldstein. 1983. Antiinflammatory effects of endotoxin. Inhibition of rabbit polymorphonuclear leukocyte responses to complement (C5)-derived peptides in vivo and in vitro.Am. J. Pathol. 113:291–299.

    Google Scholar 

  13. Verghese, M. W., andR. Snyderman. 1981. Differential antiinflammatory effects of LPS in susceptible and resistant mouse strains.J. Immunol. 127:288–293.

    Google Scholar 

  14. Milner, K. C. 1973. Patterns of tolerance to endotoxin.J. Infect. Dis. 128(Suppl):S237-S245.

    Google Scholar 

  15. Howes, E. L., Jr., M. E. Goldyne, H. D. Perez, I. M. Goldstein, andJ. T. Rosenbaum. 1985. LPS tolerance inhibits eye inflammation: I. Reduced immune complex or LPS effects.Arch Ophthalmol. 103:257–260.

    Google Scholar 

  16. Rosenbaum, J. T., K. Wong, H. D. Perez, W. Raymond, andE. L. Howes, Jr., 1984. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.Invest. Ophthalmo. Vis. Sci. 25:1184–1191.

    Google Scholar 

  17. Howes, E. L., andD. G. McKay. 1975. Comparison of the ocular effects of circulating endotoxin and immune complexes: Role of vasoactive amines.J. Immunol. 114:734–737.

    Google Scholar 

  18. Lynch, J. M., G. Z. Lotner, S. J. Betz, andP. M. Henson. 1979. The release of a plateletactivating factor by stimulated rabbit neutrophils.J. Immunol. 123:1219–1226.

    Google Scholar 

  19. Zigmond, S. H., andJ. G. Hirsch. 1973. Leukocyte locomotion and chemotaxis: New methods for evaluation and demonstration of a cell derived chemotactic factor.J. Exp. Med. 137:387–410.

    Google Scholar 

  20. Ferez, H. D., M. Lipton, andI. M. Goldstein. 1978. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.J. Clin. Invest. 62:29–38.

    Google Scholar 

  21. Henson, P. M. 1971. The immunologic release of constituents from neutrophil leukocytes: II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces.J. Immunol. 107:1547–1557.

    Google Scholar 

  22. Brittinger, G., R. Hirschhorn, S. D. Douglas, andG. Weissmann. 1968. Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes.J. Cell Biol. 37:394–411.

    Google Scholar 

  23. Wacker, W. E. C., D. D. Ulmer, andB. L. Valle. 1956. Metalloenzymes and myocardial infarction. II. Malic and lactic dehydrogenase activities and zinc concentration in serum.N. Engl. J. Med. 255:449–456.

    Google Scholar 

  24. Crawford, J. P., H. Z. Movat, N. S. Ranadive, andH. B. Hay. 1982. Pathways to inflammation induced by immune complexes: Development of Arthus reactions.Fed. Proc. 41:2583–2587.

    Google Scholar 

  25. Sultzer, B. M. 1968. Genetic control of leukocyte responses to endotoxin.Nature 219:1253–1254.

    Google Scholar 

  26. Herring, W. B., J. C. Heroin, R. I. Walker, andG. Palmer. 1973. Distribution and clearance of circulating endotoxin.J. Clin. Invest. 42:79–87.

    Google Scholar 

  27. Alper, C. A., andF. S. Rosen. 1967. Studies of the in vivo behavior of human C3 in normal subjects and patients.J. Clin. Invest. 46:2021–2034.

    Google Scholar 

  28. Kunkell, S. L., R. S. Thrall, R. G. Kunkell, J. R. Mccormick, P. A. Ward, andR. B. Zurier. 1979. Suppression of immune complex vasculitis in rats by prostaglandin.J. Clin. Invest. 64:1525–1529.

    Google Scholar 

  29. Bourne, H. R., L. M. Lichentenstein, K. L. Melmon, C. S. Henney, Y. Weinstein, andG. M. Shearer. 1974. Modulation of inflammation and immunity by cyclic AMP. Receptors for vasoactive hormones and mediators of inflammation regulate many leukocyte functions.Science 184:19–28.

    Google Scholar 

  30. Jacobs, E. R., M. E. Soulsby, R. C. Bone, F. J. Wilson, andF. C. Hiller. 1972. Ibuprofen in canine endotoxin shock.J. Clin. Invest. 70:536–541.

    Google Scholar 

  31. Johnson, K. J., andP. A. Ward. 1970. Protective function of C6 in rabbits treated with bacterial endotoxin.J. Immunol. 106:1125–1127.

    Google Scholar 

  32. Solomon, H. C., andI. Kopp. 1937. Fever therapy.N. Engl. J. Med. 217:805–814.

    Google Scholar 

  33. Fossard, D. P., V. V. Kakkar, andP. A. Elsey. 1974. Assessment of limulus test for detecting endotoxemia.Br. Med. J. 2:465–468.

    Google Scholar 

  34. Link, A. S., D. A. Bass, andC. E., McCall. 1979. Altered neutrophil migration during bacterial infection associated with a serum modulator of cellular motility.J. Infect. Dis. 140:517–526.

    Google Scholar 

  35. Solomkin, J. S., M. K. Jenkins, R. D. Nelson, D. Chenoweth, andR. L. Simmons. 1981. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.Surgery 90:319–326.

    Google Scholar 

  36. Hill, H. R., J. M. Gerrard, N. A. Hogan, andP. G. Quie. 1974. Hyperactivity of neutrophil leukotactic responses during active bacterial infection.J. Clin. Invest. 53:996–1002.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenbaum, J.T., Hartiala, K.T., Howes, E.L. et al. Endotoxin tolerance diminishes certain antiinflammatory effects of endotoxin. Inflammation 9, 297–308 (1985). https://doi.org/10.1007/BF00916278

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00916278

Keywords

Navigation